MAPT and Alzheimer disease: Numerous reports have revealed a relationship between the activation of MAPKs and accumulation of pathological aggregates of beta-amyloid (Aβ) and hyperphosphorylated tau protein in neurofibrillary plaques [2,3] as well as neuroinflammation [4], oxidative stress, and other hallmarks of AD.